Paulette A. Lyle

1.7k total citations
42 papers, 1.3k citations indexed

About

Paulette A. Lyle is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Nephrology. According to data from OpenAlex, Paulette A. Lyle has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cardiology and Cardiovascular Medicine, 19 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Nephrology. Recurrent topics in Paulette A. Lyle's work include Blood Pressure and Hypertension Studies (27 papers), Hormonal Regulation and Hypertension (14 papers) and Chronic Kidney Disease and Diabetes (8 papers). Paulette A. Lyle is often cited by papers focused on Blood Pressure and Hypertension Studies (27 papers), Hormonal Regulation and Hypertension (14 papers) and Chronic Kidney Disease and Diabetes (8 papers). Paulette A. Lyle collaborates with scholars based in United States, Denmark and Sweden. Paulette A. Lyle's co-authors include William F. Keane, Richard B. Devereux, Steven Snapinn, Shahnaz Shahinfar, Barry M. Brenner, Edward L. Engelhardt, Walfred S. Saari, Hans Ibsen, Robert D. Toto and Sverre E. Kjeldsen and has published in prestigious journals such as Diabetes Care, Kidney International and The American Journal of Medicine.

In The Last Decade

Paulette A. Lyle

42 papers receiving 1.2k citations

Peers

Countries citing papers authored by Paulette A. Lyle

Since Specialization

Citations

This map shows the geographic impact of Paulette A. Lyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paulette A. Lyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paulette A. Lyle more than expected).

Fields of papers citing papers by Paulette A. Lyle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paulette A. Lyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paulette A. Lyle. The network helps show where Paulette A. Lyle may publish in the future.

Co-authorship network of co-authors of Paulette A. Lyle

This figure shows the co-authorship network connecting the top 25 collaborators of Paulette A. Lyle. A scholar is included among the top collaborators of Paulette A. Lyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paulette A. Lyle. Paulette A. Lyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study 2009 ·Blood Pressure ·Sverre E. Kjeldsen, Richard B. Devereux, Darcy A. Hille, Paulette A. Lyle, Björn Dahlöf, Stevo Julius, Jonathan M. Edelman, Steven Snapinn, Ulf dé Fairé, Frej Fyhrquist, Hans Ibsen, Ole Lederballe‐Pedersen, Lars Lindholm, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel, (unknown)	15
2	Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study 2009 ·Journal of Hypertension ·Michael Hecht Olsen, Kristian Wachtell, Gareth Beevers, Björn Dahlöf, Giovanni de Simone, Richard B. Devereux, Ulf dé Fairé, F Fyhrquist, Hans Ibsen, Sverre E. Kjeldsen, Ole Lederballe‐Pedersen, Lars Lindholm, Paulette A. Lyle, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel	17
3	ACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy 2008 ·Journal of the American Society of Nephrology ·Hans‐Henrik Parving, Dick de Zeeuw, Mark E. Cooper, Giuseppe Remuzzi, Nancy Liu, Jared Lunceford, Shahnaz Shahinfar, Peggy H. Wong, Paulette A. Lyle, Peter Rossing, Barry M. Brenner	70
4	The effect of losartan on hemoglobin concentration and renal outcome in diabetic nephropathy of type 2 diabetes 2007 ·Kidney International ·(unknown), (unknown), S. Shahinfar, Paulette A. Lyle, Robert D. Toto	55
5	Atenolol as a comparator in outcome trials in hypertension: A correct choice in the past, but not for the future? 2007 ·Blood Pressure ·Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen, Paulette A. Lyle, Zhongxin Zhang, Jonathan M. Edelman	7
6	Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study 2007 ·Journal of Human Hypertension ·Giovanni de Simone, Michael Hecht Olsen, Kristian Wachtell, Darcy A. Hille, Björn Dahlöf, Hans Ibsen, Sverre E. Kjeldsen, Paulette A. Lyle, Richard B. Devereux	42
7	Effect of Hemoglobin Levels on Cardiovascular Outcomes in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy (from the LIFE Study) 2007 ·The American Journal of Cardiology ·(unknown), (unknown), Aud Høieggen, Arnljot Flaa, Ingrid Os, Sverre E. Kjeldsen, Michael Hecht Olsen, Arghya Chattopadhyay, Darcy A. Hille, Paulette A. Lyle, Richard B. Devereux, Björn Dahlöf	8
8	The effect of angiotensin receptor blockers for preventing atrial fibrillation 2007 ·Current Hypertension Reports ·Kristian Wachtell, Richard B. Devereux, Paulette A. Lyle	3
9	Use of beta-blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers to prevent atrial fibrillation 2006 ·Current Cardiology Reports ·Kristian Wachtell, Richard B. Devereux, Paulette A. Lyle	4
10	Losartan: lessons learned from the RENAAL study 2006 ·Expert Opinion on Pharmacotherapy ·Shahnaz Shahinfar, Paulette A. Lyle, Zhongxin Zhang, William F. Keane, Barry M. Brenner	6
11	The Effects of Losartan Compared to Atenolol on Stroke in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy. The LIFE Study 2005 ·Journal of Clinical Hypertension ·Sverre E. Kjeldsen, Paulette A. Lyle, Jorge R. Kizer, Björn Dahlöf, Richard B. Devereux, Stevo Julius, Gareth Beevers, Ulf dé Fairé, Frej Fyhrquist, Hans Ibsen, Krister Kristianson, Ole Lederballe‐Pedersen, Lars Lindholm, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Steven Snapinn, Katherine E. Harris, Hans Wedel	30
12	Losartan and the United States costs of end-stage renal disease by baseline albuminuria in patients with type 2 diabetes and nephropathy 2004 ·Kidney International ·Charles M. Alexander, Paulette A. Lyle, William F. Keane, George W. Carides, Zhongxin Zhang, Shahnaz Shahinfar	12
13	Hypertension and medical informatics. 2003 ·PubMed Central ·W. G. McBride, Carlos M. Ferrario, Paulette A. Lyle	8
14	An analysis of cholesterol control and statin use in the losartan intervention for endpoint reduction in hypertension study 2003 ·Clinical Therapeutics ·Krister Kristianson, F Fyhrquist, Richard B. Devereux, Sverre E. Kjeldsen, Lars Lindholm, Paulette A. Lyle, Markku S. Nieminen, Steven Snapinn	8
15	A multicenter, randomized, double-blind, placebo-controlled, 8-week trial of the efficacy and tolerability of once-daily losartan 100 mg/hydrochlorothiazide 25 mg and losartan 50 mg/hydrochlorothiazide 12.5 mg in the treatment of moderate-to-severe essential hypertension 2002 ·Clinical Therapeutics ·Alan H. Gradman, William E. Brady, (unknown), Paulette A. Lyle, Robert K. Zeldin	26
16	First-dose effects of enalapril 2.5 mg and captopril 6.25 mg in patient with heart failure: A double-blind, randomized, multicenter study 1994 ·American Heart Journal ·Roberto M. Lang, Robert DiBianco, (unknown), Stephen S. Gottlieb, John B. Kostis, Paulette A. Lyle, Lukas Makris, Sol I. Rajfer, Ewa Rucinska, (unknown)	13
17	Cyclization-activated prodrugs. Basic esters of 5-bromo-2'-deoxyuridine 1990 ·Journal of Medicinal Chemistry ·Walfred S. Saari, (unknown), Paulette A. Lyle, Sheri Smith, Edward L. Engelhardt	33
18	Synthesis and pharmacological evaluation of a series of dibenzo[a,d]cycloalkenimines as N-methyl-D-aspartate antagonists 1990 ·Journal of Medicinal Chemistry ·Wayne J. Thompson, Paul Anderson, Susan F. Britcher, Terry A. Lyle, (unknown), Catherine Magill, Sándor Varga, (unknown), Paulette A. Lyle	55
19	Cyclization-activated prodrugs. Basic carbamates of 4-hydroxyanisole 1990 ·Journal of Medicinal Chemistry ·Walfred S. Saari, (unknown), Paulette A. Lyle, Steven J. Smith, Edward L. Engelhardt	89
20	Safety and tolerability of lisinopril in older hypertensive patients 1988 ·The American Journal of Medicine ·Janet E. Rush, Paulette A. Lyle	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact